Sanginita Chemicals Ltd. (IN:SANGINITA)
:SANGINITA
Top Page
Sanginita Chemicals Ltd.
(SANGINITA)
Select Model
Select Model
Rating:43Neutral
Price Target:―
Action:ReiteratedDate:12/30/25
The score is primarily held back by weak and fragile financial performance—especially volatile operating cash flow and recurring negative free cash flow, alongside extremely thin margins. Balance-sheet leverage has improved, but low ROE suggests the stronger capital structure is not translating into strong returns. Technical and valuation inputs were not available, limiting non-fundamental conviction.
Positive Factors
Improving Leverage
The decline in debt-to-equity ratio indicates better financial health and reduced risk, providing more flexibility for future investments.
Negative Factors
Volatile Cash Flow
Inconsistent cash flow generation poses risks to financial stability and limits the company's ability to fund growth initiatives.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving Leverage
The decline in debt-to-equity ratio indicates better financial health and reduced risk, providing more flexibility for future investments.
Read all positive factors
Sanginita Chemicals Ltd. (SANGINITA) vs. iShares MSCI India ETF (INDA)
Market Cap
N/A
Dividend YieldN/A
Average Volume (3M)N/A
Price to Earnings (P/E)―
Beta (1Y)N/A
Revenue Growth0.45%
EPS Growth-242.94%
CountryIN
Employees60
SectorBasic Materials
Sector Strength58
IndustryChemicals
Share Statistics
EPS (TTM)-1.07
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio-0.92
Price to Book (P/B)0.52
Price to Sales (P/S)0.13
P/FCF Ratio-3.49
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Sanginita Chemicals Ltd. Business Overview & Revenue Model
Company Description
Sanginita Chemicals Limited manufactures and exports cuprous chloride, cupric chloride, and copper sulphate in India. The company also offers copper phthalocyanine blue crude. Its products are used in dyes and pigment industries, paint industries,...
How the Company Makes Money
Sanginita Chemicals Ltd. generates revenue through the sale of its specialty chemical products to various sectors, including agriculture, textiles, and pharmaceuticals. The company’s revenue model is primarily based on direct sales to manufacturer...
Sanginita Chemicals Ltd. Financial Statement Overview
Summary
Income Statement
38
Negative
Balance Sheet
58
Neutral
Cash Flow
22
Negative
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.01B | 2.30B | 1.52B | 1.49B | 1.98B | 1.65B |
| Gross Profit | 56.06M | 52.91M | 49.17M | 72.70M | 61.60M | 71.11M |
| EBITDA | 37.34M | 49.43M | 44.09M | 36.05M | 31.10M | 41.93M |
| Net Income | -4.83M | 6.18M | 7.70M | 4.16M | 3.48M | 7.63M |
Balance Sheet | ||||||
| Total Assets | 1.02B | 1.02B | 859.29M | 794.99M | 792.04M | 701.22M |
| Cash, Cash Equivalents and Short-Term Investments | 133.00K | 129.00K | 205.00K | 272.00K | 149.00K | 84.00K |
| Total Debt | 263.72M | 263.76M | 328.66M | 285.80M | 345.14M | 289.51M |
| Total Liabilities | 468.23M | 461.57M | 451.35M | 393.62M | 394.83M | 307.49M |
| Stockholders Equity | 555.75M | 561.45M | 407.94M | 401.37M | 397.21M | 393.73M |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -83.50M | -62.01M | 128.14M | -36.34M | 82.32M |
| Operating Cash Flow | 0.00 | 8.42M | -22.96M | 137.01M | -29.88M | 85.11M |
| Investing Cash Flow | 0.00 | -99.00M | -38.70M | -7.29M | -4.96M | -1.37M |
| Financing Cash Flow | 0.00 | 90.51M | 61.60M | -129.59M | 34.90M | -83.93M |
Sanginita Chemicals Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ₹7.03B | 17.61 | ― | 0.81% | 33.39% | 85.08% | |
65 Neutral | ₹5.73B | 12.55 | ― | 0.63% | 7.23% | 5.00% | |
62 Neutral | ₹2.04B | 34.22 | ― | 1.11% | -37.34% | -45.55% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ₹5.43B | -2.39 | ― | 1.25% | -37.44% | -950.73% | |
43 Neutral | ― | -2.38 | ― | ― | 0.45% | -242.94% |
* Basic Materials Sector Average
IN:SANGINITA
Sanginita Chemicals Ltd.
―
―
―
IN:20MICRONS
20 Microns Limited
162.40
-42.18
-20.62%
IN:BHAGERIA
Bhageria Industries Ltd.
161.15
1.38
0.86%
IN:CHEMBOND
Chembond Chemicals Limited
152.05
-298.70
-66.27%
IN:OMKARCHEM
Omkar Speciality Chemicals Limited
4.45
-1.40
-23.93%
IN:SADHNANIQ
Sadhana Nitro Chem Limited
1.83
-3.84
-67.72%
Sanginita Chemicals Ltd. Corporate Events
Sanginita Chemicals Files Q3 FY2025 Unaudited Results, Auditors Flag No Material Misstatements
Jan 10, 2026
Sanginita Chemicals Limited has reported its unaudited financial results for the quarter ended 31 December 2025, following approval by the board of directors at a meeting held on 10 January 2026. The company confirmed that its statutory auditors c...
Sanginita Chemicals Appoints New Compliance Officer
Nov 1, 2025
Sanginita Chemicals Ltd. has announced the appointment of Ms. Saroj Jagetia as the new Compliance Officer, effective November 1, 2025. This strategic appointment, based on the recommendation of the Nomination and Remuneration Committee, is expecte...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.